MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-12-2026
Repro Med Systems Retained Earnings 2011-2026 | KRMD
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Repro Med Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -32 M | -29.4 M | -23.3 M | -9.57 M | -910 K | 3.65 M | 4.86 M | 4.3 M | 2.48 M | 3.02 M | 2.24 M | 1.48 M | 781 K | 54.8 K | -761 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.86 M | -32 M | -4.87 M |
Quarterly Retained Earnings Repro Med Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -31.5 M | -30.8 M | -30.5 M | -29.4 M | -27.8 M | -26.2 M | -25.2 M | -23.3 M | -15.8 M | -14.5 M | -12 M | -9.57 M | -7.59 M | - | -3.45 M | -910 K | 158 K | 1.25 M | 2.38 M | 3.65 M | 3.65 M | 3.65 M | 3.65 M | 4.86 M | 4.86 M | 4.86 M | 4.86 M | 4.3 M | 4.3 M | 4.3 M | 4.3 M | 3.39 M | 3.39 M | 3.39 M | 3.39 M | 2.6 M | 2.7 M | 2.79 M | 3.02 M | 2.68 M | 2.51 M | 2.17 M | 2.24 M | 1.94 M | 1.85 M | 1.64 M | 1.48 M | 1.11 M | 945 K | 854 K | 781 K | 551 K | 496 K | 145 K | 54.8 K | -263 K | -445 K | - | -761 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.86 M | -31.5 M | -3.32 M |
Retained Earnings of other stocks in the Medical instruments industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AtriCure
ATRC
|
-413 M | $ 28.22 | -2.32 % | $ 1.35 B |  USA |
 |
Baxter International
BAX
|
13.7 B | $ 17.24 | 3.61 % | $ 8.84 B | USA |
 |
Atrion Corporation
ATRI
|
382 K | - | - | $ 810 M | USA |
 |
BioLife Solutions
BLFS
|
-335 M | $ 19.71 | 3.03 % | $ 908 M | USA |
 |
Luminex Corporation
LMNX
|
83.8 M | - | - | $ 1.75 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-262 M | $ 8.73 | -3.64 % | $ 21.2 M | USA |
 |
Akers Biosciences, Inc.
AKER
|
-120 M | - | -9.52 % | $ 20.6 M | USA |
 |
Alcon
ALC
|
19.4 B | $ 77.31 | 3.54 % | $ 40.4 B |  Schweiz |
 |
Haemonetics Corporation
HAE
|
352 M | $ 59.53 | -0.05 % | $ 3 B | USA |
 |
Harvard Bioscience
HBIO
|
-215 M | $ 5.55 | 2.78 % | $ 246 M | USA |
 |
The Cooper Companies
COO
|
7.64 B | $ 71.73 | 2.97 % | $ 14.3 B | USA |
 |
iRhythm Technologies
IRTC
|
-803 M | $ 120.49 | 1.57 % | $ 3.86 B | USA |
 |
Isoray
ISR
|
-335 M | - | 0.03 % | $ 108 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
-223 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
548 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
-11.9 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.13 B | - | -0.05 % | $ 10.3 B | USA |
 |
Masimo Corporation
MASI
|
1.49 B | $ 178.3 | -0.24 % | $ 9.5 B | USA |
 |
Microbot Medical
MBOT
|
-104 M | $ 2.35 | 2.62 % | $ 108 M |  Israel |
 |
Varian Medical Systems, Inc.
VAR
|
1.13 B | - | -0.02 % | $ 16.3 B | USA |
 |
Milestone Scientific
MLSS
|
-134 M | $ 0.27 | -4.66 % | $ 22.2 M | USA |
 |
Merit Medical Systems
MMSI
|
824 M | $ 69.24 | 2.73 % | $ 4.1 B | USA |
 |
electroCore
ECOR
|
-191 M | $ 6.21 | -7.45 % | $ 52.7 K | USA |
 |
Envista Holdings Corporation
NVST
|
-440 M | $ 26.66 | 5.42 % | $ 4.48 B | USA |
 |
Pro-Dex
PDEX
|
35.9 M | $ 48.97 | -1.63 % | $ 161 M | USA |
 |
Glaukos Corporation
GKOS
|
-599 M | $ 118.62 | 3.09 % | $ 5.75 B | USA |
 |
Predictive Oncology
POAI
|
-414 M | - | - | $ 31.1 M | USA |
 |
ICU Medical
ICUI
|
691 M | $ 123.92 | 3.41 % | $ 3.05 B | USA |
 |
InfuSystem Holdings
INFU
|
-59.3 M | $ 9.47 | 1.18 % | $ 196 M | USA |
 |
Intuitive Surgical
ISRG
|
7.01 B | $ 462.28 | 2.06 % | $ 165 B | USA |
 |
ResMed
RMD
|
3.61 B | $ 230.7 | 2.06 % | $ 33.7 B | USA |
 |
LeMaitre Vascular
LMAT
|
185 M | $ 112.41 | 1.89 % | $ 2.54 B | USA |
 |
Retractable Technologies
RVP
|
13.9 M | $ 0.68 | -4.59 % | $ 20.4 M | USA |
 |
Pulse Biosciences
PLSE
|
-463 M | $ 19.06 | -4.51 % | $ 1.28 B | USA |
 |
STAAR Surgical Company
STAA
|
-148 M | $ 20.88 | -1.0 % | $ 1.03 B | USA |
 |
STERIS plc
STE
|
2.48 B | $ 225.03 | 2.65 % | $ 22.2 B | USA |
 |
Stereotaxis
STXS
|
-583 M | $ 1.93 | 4.32 % | $ 176 M | USA |
 |
NeuroMetrix
NURO
|
-218 M | - | 5.05 % | $ 9.02 M | USA |
 |
Teleflex Incorporated
TFX
|
3.15 B | $ 119.03 | 3.05 % | $ 5.31 B | USA |
 |
Utah Medical Products
UTMD
|
129 M | $ 64.53 | 1.67 % | $ 209 M | USA |
 |
West Pharmaceutical Services
WST
|
4.37 B | $ 265.93 | 2.54 % | $ 19.2 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-1.56 B | $ 11.99 | 4.08 % | $ 2.39 B | USA |
 |
AngioDynamics
ANGO
|
-429 M | $ 10.17 | 4.85 % | $ 415 M | USA |
 |
Becton, Dickinson and Company
BDX
|
16.6 B | $ 157.09 | 1.37 % | $ 45.2 B | USA |
 |
Nephros
NEPH
|
-144 M | $ 2.91 | 4.68 % | $ 30.2 M | USA |
 |
OraSure Technologies
OSUR
|
-172 M | $ 3.08 | 0.65 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
433 M | $ 119.77 | 3.89 % | $ 6.67 M | USA |